HIGHLIGHTS
- who: Nuria Cu00e1rdenas-Quesada and collaborators from the Medical Oncology Unit, University Hospital of Jau00e9n, Jau00e9n, Spain have published the research: TFG- Nuclear Staining as a Potential Relapse Risk Factor in Early-Stage Non-Small-Cell Lung Cancer, in the Journal: (JOURNAL) of 21/09/2022
- what: The authors aimed to evaluate the association of clinicopathologic characteristics and the prognostic value of PDL-1 expression and TILs, and explored the immune microenvironment by assessing their relationship, since they have been suggested as clinically applicable predictive biomarkers in surgically resectable NSCLC. The analysis showed higher expression . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.